Tom Ayton1, Svetlana Cherepanoff2,3, David Gottlieb4,5, William A Sewell2,3,6, Sandy Smith4, Claire Hooper7,8. 1. University of New South Wales, Sydney, Australia. tom.ayton@hotmail.com. 2. University of New South Wales, Sydney, Australia. 3. St Vincent's Hospital, Sydney, Australia. 4. Westmead Hospital, Sydney, Australia. 5. University of Sydney, Sydney, Australia. 6. Garvan Institute of Medical Research, Sydney, Australia. 7. University of Sydney, Sydney, Australia. cy_hoooper@hotmail.com. 8. Save Sight Institute , Sydney, Australia. cy_hoooper@hotmail.com.
Abstract
BACKGROUND: Solitary extramedullary plasmacytoma (SEP) is a localised proliferation of monoclonal plasma cells involving soft tissue with no or minimal bone marrow involvement and no other systemic evidence of multiple myeloma. Intraocular involvement is exceedingly rare. CASE PRESENTATION: We report a 78-year-old man who was referred with glaucoma in the right eye. He subsequently developed anterior chamber (AC) inflammation and refractory glaucoma then dense vitritis. A vitrectomy was performed with the biopsy revealing numerous plasma cells with atypical findings. In conjunction with the flow cytometry results, and a systemic work up excluding multiple myeloma, a diagnosis of SEP was made. The patient was treated with ocular external beam radiotherapy with resolution of the intraocular inflammation and control of the intraocular pressure. He remains well with no local recurrence and no development of multiple myeloma over a follow up period of 2.5 years. CONCLUSIONS: This is the first case report of SEP presenting as intraocular inflammation without a uveal tract mass.
BACKGROUND: Solitary extramedullary plasmacytoma (SEP) is a localised proliferation of monoclonal plasma cells involving soft tissue with no or minimal bone marrow involvement and no other systemic evidence of multiple myeloma. Intraocular involvement is exceedingly rare. CASE PRESENTATION: We report a 78-year-old man who was referred with glaucoma in the right eye. He subsequently developed anterior chamber (AC) inflammation and refractory glaucoma then dense vitritis. A vitrectomy was performed with the biopsy revealing numerous plasma cells with atypical findings. In conjunction with the flow cytometry results, and a systemic work up excluding multiple myeloma, a diagnosis of SEP was made. The patient was treated with ocular external beam radiotherapy with resolution of the intraocularinflammation and control of the intraocular pressure. He remains well with no local recurrence and no development of multiple myeloma over a follow up period of 2.5 years. CONCLUSIONS: This is the first case report of SEP presenting as intraocularinflammation without a uveal tract mass.
Authors: J F San Miguel; M B Vidriales; E Ocio; G Mateo; F Sánchez-Guijo; M L Sánchez; L Escribano; A Bárez; M J Moro; J Hernández; C Aguilera; R Cuello; J García-Frade; R López; J Portero; A Orfao Journal: Semin Oncol Date: 2003-04 Impact factor: 4.929
Authors: Daniel N Tran; Sandy A B C Smith; David A Brown; Andrew J C Parker; Joanne E Joseph; Nicola Armstrong; William A Sewell Journal: Cytometry B Clin Cytom Date: 2016-08-05 Impact factor: 3.058
Authors: Sridevi Hanaganahalli Basavaiah; Flora D Lobo; Cheryl Sarah Philipose; Pooja K Suresh; Saraswathy Sreeram; Hema Kini; Kausalya K Sahu; Krishna Prasad Journal: BMC Cancer Date: 2019-08-14 Impact factor: 4.430
Authors: J Caers; B Paiva; E Zamagni; X Leleu; J Bladé; S Y Kristinsson; C Touzeau; N Abildgaard; E Terpos; R Heusschen; E Ocio; M Delforge; O Sezer; M Beksac; H Ludwig; G Merlini; P Moreau; S Zweegman; M Engelhardt; L Rosiñol Journal: J Hematol Oncol Date: 2018-01-16 Impact factor: 17.388